Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 734 of 6351
-
Higher-Dose eye injection shows promise for two leading causes of vision loss
Disease control OngoingThis study is researching aflibercept high dose (HD), referred to as "study drug", with an experimental dosing regimen. The study is focused on participants with nAMD and DME that have been previously treated with anti-vascular endothelial growth factor (anti-VEGF) medications. …
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for kidney transplant patients with advanced skin cancer
Disease control Recruiting nowThis phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Single shot aims to stop liver cancer recurrence
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of administration of intratumoral IP-001 injection at different dosages (volume and concentration) following local microwave ablation (MWA) or surgical resection and ablation in patients with hepatocellular carcinom…
Phase 2 • Sponsor: Robert C. Martin • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New stroke treatment Y-3 aims to boost recovery in first 48 hours
Disease control CompletedThis trial aims to evaluate the effectiveness and safety of Y-3 for injection in the treatment of patients with acute ischemic stroke within 48 hours of onset
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Triple-Drug cocktail aims to extend life in tough stomach cancer
Disease control Recruiting nowThis study employs a randomized, controlled, exploratory clinical trial design, with a planned enrollment of 66 patients who have previously failed systemic chemotherapy for recurrent/metastatic gastric cancer,
Phase 2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New injectable methotrexate aims to tame rheumatoid arthritis with fewer side effects
Disease control OngoingThe goal of this clinical trial is to evaluate the efficacy of FBL-MTX administered by subcutaneous route in Rheumatoid Arthritis patients. Participants will be screened within 28 days prior to treatment period, to confirm that they meet the selection criteria for the study. Tr…
Phase 2 • Sponsor: SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could amniotic membrane ease bladder pain? new trial seeks answers
Disease control Recruiting nowInterstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/ or discomfort associated with urinary frequency and urgency. The primary objective of this study is to determine the …
Phase 2/3 • Sponsor: David Sheyn • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a home feeding coach keep dementia patients out of the hospital?
Disease control By invitation onlyThe main goal of this single-blinded multicenter randomized trial is to learn if the 8-week home-based Feeding EnhancEment in Dementia program (FEED@home) works to improve unplanned hospital utilization of advanced dementia patients with feeding problems who reside at home after …
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug plozasiran aims to tame dangerous fat levels in blood
Disease control OngoingThis Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (SHTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozas…
Phase 3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for rare hunger disorder: drug shows promise in Long-Term trial
Disease control Stopped earlyThe goal of this clinical trial is to learn if ARD-101 works to treat hyperphagia-related behavior in patients with Prader-Willi syndrome (PWS) when used in a long term setting. It will also teach us about the safety of ARD-101. The main questions it aims to answer are: What me…
Phase 3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New combo therapy shows promise for common lung cancer mutation
Disease control OngoingTo estimate parameters related to clinical outcomes in a real-world seeting, including investigator reported PFS and OS .
Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Your phone could soon diagnose asthma and COPD with sound waves
Diagnosis Recruiting nowThe study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.
Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New hope for High-Risk myeloma: drug combo shows promise in early trial
Disease control OngoingThis phase II trial compares the combination of selinexor, daratumumab and hyaluronidase-fihj (daratumumab), velcade (bortezomib), and dexamethasone (Dara-SVD) to the usual treatment of daratumumab, lenalidomide, bortezomib, and dexamethasone (Dara-RVD) in treating patients with …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for kids with tough leukemia: blinatumomab trial shows promise
Disease control OngoingThe primary objective of this study is to evaluate the efficacy of blinatumomab.
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Portable MRI could spot brain injury in children on life support
Diagnosis Recruiting nowThe primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECM…
Sponsor: Children's Mercy Hospital Kansas City • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Strawberry compound and exercise may keep breast cancer survivors from becoming frail
Prevention Recruiting nowThis phase II trial tests how well fisetin and exercise works in preventing frailty in breast cancer survivors. Fisetin is a natural substance found in strawberries and other foods and is available as a nutritional supplement. Nutritional supplements may be useful in eliminating …
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Experimental antibody may boost leukemia treatment
Disease control OngoingThe goal of this clinical trial is to learn if participants treated with the experimental drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to venetoclax and azacitidine. Venetoclax and azacitidine are drugs commonly used to…
Phase 2 • Sponsor: OncoVerity, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for aggressive lung cancer: combo therapy enters human trials
Disease control Recruiting nowThis study is designed to evaluate the safety and efficacy of ifinatamab deruxtecan (I-DXd) in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung cancer (ES-SCLC) in the first-line (1L) …
Phase 1/2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo therapy aims to keep advanced breast cancer in check
Disease control OngoingDEMETHER is a phase II trial exploring the maintenance of trastuzumab and pertuzumab fixed dose combination (FDC) for subcutaneous administration (SC, PHESGO) following trastuzumab deruxtecan (T-DXd) as induction treatment for HER2-positive unresectable locally recurrent or metas…
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a Brain-Zapping device restore steady steps and sharp thinking?
Symptom relief CompletedThis clinical trial aims to explore the effectiveness and safety of gait improvemen of Neuclare, a science medical device, for patients with Idiopathic Normal Pressure Hydrocephalus (iNPH) Through methods such as Timed Up \& Go Test (TUG), 10m gait , iNPH grading scale), etc, gai…
Sponsor: Deepsonbio • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC